.Merck beats incomes desires, rears purchases overview on sturdy requirement for top medicines like Keytruda CNBCMerck & Co. (MRK US) Defeats Earnings Projections as Keytruda Sales Increase BloombergMerck Stock: Pharma Giant Posts Powerful Outcomes, But Expectation Falls Short Client's Service DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats revenue and also sales desires surrounded by Keytruda advantage, however supplies blended full-year expectation MarketWatch.